Cargando…
Immunotherapeutic potential of JL1, a thymocyte surface protein, for leukemia.
Tumor-specific antigens for leukemia cells have been sought for the past decades, but none of cell surface markers met sufficient criteria as a 'phenotypic signature'. Here we suggest that JL1 antigen can be efficiently used for diagnosis and treatment. JL1 is a human thymocyte differentia...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Korean Academy of Medical Sciences
1998
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054527/ https://www.ncbi.nlm.nih.gov/pubmed/9811172 |